Bendopnea prevalence and prognostic value in older patients with heart failure: FRAGILE-HF-SONIC-HF post hoc analysis.

Heart failure bendopnea frailty prognosis

Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
04 Apr 2024
Historique:
received: 12 12 2023
revised: 27 02 2024
accepted: 03 04 2024
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 4 4 2024
Statut: aheadofprint

Résumé

This study aimed to investigate the prevalence, clinical characteristics, and prognostic value of bendopnea in older patients hospitalized for heart failure. This post hoc analysis was performed using two prospective, multicenter, observational studies: the FRAGILE-HF (main cohort) and SONIC-HF (validation cohort) cohorts. Patients were categorized based on the presence of bendopnea, which was evaluated before discharge. The primary endpoint was 2-year all-cause mortality after discharge. Among the 1,243 patients (median age, 81 years; 57.2% male) in the FRAGILE-HF cohort and 225 (median age, 79 years; 58.2% men) in the SONIC-HF cohort, bendopnea was observed in 31 (2.5%) and 10 (4.4%) patients, respectively. Over a 2-year follow-up period, all-cause death occurred in 20.8% and 21.9% of the patients in the FRAGILE-HF and SONIC-HF cohorts, respectively. Kaplan-Meier survival curves demonstrated significantly higher mortality rates in patients with bendopnea than in those without bendopnea in the FRAGILE-HF (log-rank P = 0.006) and SONIC-HF cohorts (log-rank P = 0.014). Cox proportional hazard analysis identified bendopnea as an independent prognostic factor for all-cause mortality in both the FRAGILE-HF (hazard ratio [HR] 2.11, 95% confidence interval [CI] 1.18-3.78, P = 0.012) and SONIC-HF cohorts (HR 4.20, 95% CI 1.63-10.79, P = 0.003), even after adjusting for conventional risk factors. Bendopnea was observed in a relatively small proportion of older patients hospitalized for heart failure before discharge. However, its presence was significantly associated with an increased risk of all-cause mortality. This study investigated how common it is for older patients with heart failure to have trouble breathing when they bend forward, and whether this affects their chances of survival. The study found that although this problem is not very common, it is linked to a higher risk of death. Key findings: Only a small number of older patients with heart failure have trouble breathing when they bend forward.However, those who do have this problem are more likely to die.

Autres résumés

Type: plain-language-summary (eng)
This study investigated how common it is for older patients with heart failure to have trouble breathing when they bend forward, and whether this affects their chances of survival. The study found that although this problem is not very common, it is linked to a higher risk of death. Key findings: Only a small number of older patients with heart failure have trouble breathing when they bend forward.However, those who do have this problem are more likely to die.

Identifiants

pubmed: 38573843
pii: 7640885
doi: 10.1093/eurjpc/zwae128
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Taisuke Nakade (T)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Daichi Maeda (D)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Yuya Matsue (Y)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Yudai Fujimoto (Y)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Nobuyuki Kagiyama (N)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Digital Health and Telemedicine R&D, Juntendo University, Tokyo, Japan, Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Tsutomu Sunayama (T)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Taishi Dotare (T)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Kentaro Jujo (K)

Department of Cardiology, Nishiarai Heart Centre Hospital, Tokyo, Japan.

Kazuya Saito (K)

Department of Rehabilitation, The Sakakibara Heart Institute of Okayama, Okayama, Japan.

Kentaro Kamiya (K)

Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.

Hiroshi Saito (H)

Department of Rehabilitation, Kameda Medical Centre, Kamogawa, Japan.

Yuki Ogasahara (Y)

Department of Nursing, The Sakakibara Heart Institute of Okayma, Okayama, Japan.

Emi Maekawa (E)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Masaaki Konishi (M)

Division of Cardiology, Yokohama City University Medical Centre, Yokohama, Japan.

Takeshi Kitai (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Osaka, Japan.

Kentaro Iwata (K)

Department of Rehabilitation, Kobe City Medical Centre General Hospital, Kobe, Japan.

Misako Toki (M)

Department of Clinical Laboratory, The Sakakibara Heart Institute of Okayama, Okayama, Japan.

Kenji Yoshioka (K)

Department of Cardiology, Kameda Medical Center, Kamogawa, Japan.

Hiroshi Wada (H)

Department of Cardiovascular Medicine, Saitama Medical Centre, Jichii Medical University, Saitama, Japan.

Takatoshi Kasai (T)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Hirofumi Nagamatsu (H)

Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.

Shin-Ichi Momomura (SI)

Saitama Citizens Medical Centre, Saitama, Japan.

Tohru Minamino (T)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Tokyo, Japan.

Classifications MeSH